Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets
Dana K. Mitchell(Indiana University – Purdue University Indianapolis), Mahua Dey(University of Wisconsin Carbone Cancer Center)
Cited by 14
Related Papers
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
|Oncotarget|2017|418
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression
|Clinical Cancer Research|2023|24